What is the definition and epidemiology of respiratory distress in newborns?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Neonatal Respiratory Distress

Respiratory distress in newborns is defined as any signs of breathing difficulties characterized by tachypnea (respiratory rate >60 breaths per minute), grunting, nasal flaring, retractions, and cyanosis, representing the infant's physiological attempt to maintain adequate gas exchange and lung volume. 1, 2, 3

Clinical Definition and Key Features

  • Tachypnea is the hallmark sign, defined as a respiratory rate exceeding 60 respirations per minute in newborns 3, 4
  • Grunting represents repetitive "eh" sounds during early expiration, reflecting the infant's attempt to generate positive end-expiratory pressure and maintain functional residual capacity 2
  • Nasal flaring manifests as consistent outward movement of the ala nasi during inspiration, indicating the infant's effort to reduce inspiratory resistance 2
  • Retractions include subcostal, intercostal, and suprasternal indrawing of the chest wall during inspiration 3, 5
  • Cyanosis indicates inadequate oxygenation, with hypoxemia objectively defined as SpO₂ <93% (adjusted for altitude) 2

Severe Respiratory Distress Indicators

Severe respiratory distress requires immediate escalation of care and is characterized by:

  • Head nodding, tracheal tugging, and pronounced lower chest wall indrawing 2
  • Severe tachypnea (≥70 breaths/minute in infants 2-11 months or ≥60 breaths/minute in children 12-59 months) 2
  • Persistent hypoxemia despite supplemental oxygen 2

Epidemiology of Neonatal Respiratory Distress

Respiratory distress occurs in up to 7% of all newborn infants and accounts for 34.3% of all neonatal intensive care unit admissions, making it one of the most common reasons for neonatal hospitalization. 3, 4, 6

Overall Incidence

  • The incidence of neonatal respiratory distress ranges from 4.6% to 7% of all live births 4, 6
  • Respiratory distress represents 34.3% of all NICU admissions 6
  • The condition affects both term and preterm infants, though the etiology and severity differ significantly between these populations 4, 5

Gestational Age-Specific Risk

Preterm infants face dramatically higher risk:

  • Infants born at ≤27 weeks gestation have the highest incidence, with 90-92% requiring surfactant therapy even after antenatal steroid exposure 1
  • Infants born at <30 weeks gestation have the highest incidence of respiratory distress syndrome due to surfactant deficiency 1
  • The risk decreases progressively with advancing gestational age; at 37 weeks, the risk is three times greater than at 39-40 weeks gestation 4

Common Etiologies and Their Relative Frequencies

In term infants, the most common causes include:

  • Transient tachypnea of the newborn (15.5% of respiratory distress cases) 6
  • Meconium aspiration syndrome (21.1% of cases) 6
  • Pneumonia (14.6% of cases) 6
  • Septicemia (16.5% of cases) 6
  • Birth asphyxia (11.9% of cases) 6

In preterm infants:

  • Respiratory distress syndrome due to surfactant deficiency is the predominant cause, affecting the majority of infants born at <30 weeks gestation 1, 7
  • Approximately 80% of children with primary ciliary dyskinesia have a history of neonatal respiratory distress as term newborns, defined as need for supplemental oxygen or positive pressure ventilation for >24 hours without clear explanation 8

Risk Factors

Key risk factors that increase the incidence of respiratory distress include:

  • Elective cesarean section, particularly when performed before 39 weeks gestation, with 82.3% of transient tachypnea cases associated with cesarean delivery 4, 6
  • Prematurity, with the highest risk in infants <30 weeks gestation 1
  • Multiple gestation pregnancies 1
  • Absence of antenatal corticosteroid administration in preterm deliveries 1
  • Meconium-stained amniotic fluid 6

Mortality and Long-term Outcomes

  • The overall mortality rate from neonatal respiratory distress is 12.8% 6
  • Respiratory distress syndrome is the primary precursor to bronchopulmonary dysplasia, a chronic condition that evolves after premature birth 1
  • Survivors demonstrate persistent airway obstruction and hyperreactivity into childhood, with average FEV₁ approximately 80% of control subjects at 6-15 years of age 1

Common Pitfalls in Recognition

  • Delayed recognition of respiratory distress signs, particularly subtle grunting or nasal flaring in the first hours of life 2, 3
  • Inadequate respiratory rate assessment using brief spot checks rather than counting over a full minute 2
  • Failure to use pulse oximetry for objective assessment of hypoxemia in all infants with suspected respiratory distress 2
  • Underestimating risk in late preterm infants (35-37 weeks) who have significantly higher respiratory distress rates than term infants 4

References

Guideline

Respiratory Distress Syndrome (RDS) in Newborns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Respiratory Distress in Newborns: Clinical Signs and Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Newborn Respiratory Distress.

American family physician, 2015

Research

Respiratory distress of the term newborn infant.

Paediatric respiratory reviews, 2013

Research

Common respiratory conditions of the newborn.

Breathe (Sheffield, England), 2016

Research

Scenario of Neonatal Respiratory Distress in Tertiary Hospital.

Journal of Nepal Health Research Council, 2018

Research

New developments in neonatal respiratory management.

Pediatrics and neonatology, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.